GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Sold by CapWealth Advisors LLC

CapWealth Advisors LLC cut its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 0.7% during the fourth quarter, Holdings Channel reports. The institutional investor owned 57,306 shares of the company’s stock after selling 427 shares during the quarter. CapWealth Advisors LLC’s holdings in GE HealthCare Technologies were worth $4,431,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Fifth Third Bancorp increased its holdings in GE HealthCare Technologies by 3.9% in the fourth quarter. Fifth Third Bancorp now owns 33,632 shares of the company’s stock valued at $2,600,000 after buying an additional 1,250 shares in the last quarter. Douglas Lane & Associates LLC raised its holdings in GE HealthCare Technologies by 22.1% during the fourth quarter. Douglas Lane & Associates LLC now owns 436,253 shares of the company’s stock worth $33,731,000 after purchasing an additional 79,073 shares during the last quarter. Prio Wealth Limited Partnership boosted its position in GE HealthCare Technologies by 25.1% during the fourth quarter. Prio Wealth Limited Partnership now owns 215,317 shares of the company’s stock worth $16,648,000 after purchasing an additional 43,189 shares in the last quarter. The Manufacturers Life Insurance Company grew its holdings in GE HealthCare Technologies by 34.9% in the third quarter. The Manufacturers Life Insurance Company now owns 341,769 shares of the company’s stock valued at $23,254,000 after purchasing an additional 88,384 shares during the last quarter. Finally, Federated Hermes Inc. increased its position in shares of GE HealthCare Technologies by 90.4% in the third quarter. Federated Hermes Inc. now owns 77,689 shares of the company’s stock valued at $5,286,000 after buying an additional 36,886 shares in the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

Analysts Set New Price Targets

Several research firms recently commented on GEHC. Mizuho boosted their price objective on shares of GE HealthCare Technologies from $96.00 to $110.00 and gave the stock a “buy” rating in a research report on Thursday, April 11th. HSBC began coverage on shares of GE HealthCare Technologies in a report on Thursday, February 15th. They issued a “buy” rating and a $100.00 price target on the stock. Citigroup lifted their price objective on GE HealthCare Technologies from $88.00 to $103.00 and gave the stock a “buy” rating in a research report on Wednesday, April 3rd. UBS Group upgraded GE HealthCare Technologies from a “sell” rating to a “neutral” rating and increased their target price for the company from $66.00 to $88.00 in a report on Monday, February 12th. Finally, Argus boosted their price target on GE HealthCare Technologies from $80.00 to $110.00 and gave the stock a “buy” rating in a report on Monday, April 1st. Four research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $95.08.

GE HealthCare Technologies Trading Down 0.2 %

Shares of NASDAQ:GEHC traded down $0.20 during trading on Thursday, reaching $84.96. 465,347 shares of the stock were exchanged, compared to its average volume of 3,392,834. GE HealthCare Technologies Inc. has a 12-month low of $62.35 and a 12-month high of $94.50. The firm’s 50-day moving average price is $88.61 and its 200 day moving average price is $77.65. The company has a debt-to-equity ratio of 1.18, a quick ratio of 0.83 and a current ratio of 1.05. The firm has a market cap of $38.77 billion, a price-to-earnings ratio of 28.21, a price-to-earnings-growth ratio of 2.99 and a beta of 0.94.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings data on Tuesday, February 6th. The company reported $1.18 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.07 by $0.11. The company had revenue of $5.20 billion during the quarter, compared to analyst estimates of $5.09 billion. GE HealthCare Technologies had a net margin of 8.02% and a return on equity of 25.58%. The business’s quarterly revenue was up 5.3% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.31 earnings per share. On average, sell-side analysts anticipate that GE HealthCare Technologies Inc. will post 4.3 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th will be given a $0.03 dividend. This represents a $0.12 annualized dividend and a dividend yield of 0.14%. The ex-dividend date is Thursday, April 18th. GE HealthCare Technologies’s payout ratio is 3.97%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.